REFERENCES
Azzoli, C. G., Miller, V. A., Ng, K. K., Krug, L. M., Hensley, M. L.,
O’Reilly, E. M., … Kris, M. G. (2003). Gemcitabine-induced
peripheral edema : Report on 15 cases and review of the literature.American Journal of Clinical Oncology , 26 (3), 247‑251.
https://doi.org/10.1097/01.COC.0000017782.24458.DD
Bannister, J. P., Adebiyi, A., Zhao, G., Narayanan, D., Thomas, C. M.,
Feng, J. Y., & Jaggar, J. H. (2009). Smooth muscle cell alpha2delta-1
subunits are essential for vasoregulation by CaV1.2 channels.Circulation Research , 105 (10), 948‑955.
https://doi.org/10.1161/CIRCRESAHA.109.203620
Bannister, J. P., Bulley, S., Narayanan, D., Thomas-Gatewood, C., Luzny,
P., Pachuau, J., & Jaggar, J. H. (2012). Transcriptional upregulation
of α2δ-1 elevates arterial smooth muscle cell voltage-dependent Ca2+
channel surface expression and cerebrovascular constriction in genetic
hypertension. Hypertension (Dallas, Tex.: 1979) , 60 (4),
1006‑1015. https://doi.org/10.1161/HYPERTENSIONAHA.112.199661
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell,
W. R., Jette, A. M., … Bhasin, S. (2010). Adverse events
associated with testosterone administration. The New England
Journal of Medicine , 363 (2), 109‑122.
https://doi.org/10.1056/NEJMoa1000485
Beck, K. R., Thompson, G. R., & Odermatt, A. (2020). Drug-induced
endocrine blood pressure elevation. Pharmacological Research ,154 , 104311. https://doi.org/10.1016/j.phrs.2019.104311
Behuliak, M., Bencze, M., Polgárová, K., Kuneš, J., Vaněčková, I., &
Zicha, J. (2018). Hemodynamic Response to Gabapentin in Conscious
Spontaneously Hypertensive Rats. Hypertension (Dallas, Tex.:
1979) , 72 (3), 676‑685.
https://doi.org/10.1161/HYPERTENSIONAHA.118.09909
Bence, C., Cottencin, O., Deheul, S., Gautier, S., Bordet, R., &
Rolland, B. (2014). Baclofen-induced edema in alcohol use disorders.Journal of Clinical Pharmacology , 54 (4), 478‑481.
https://doi.org/10.1002/jcph.233
Borovac, J. A. (2016). Side effects of a dopamine agonist therapy for
Parkinson’s disease : A mini-review of clinical pharmacology. The
Yale Journal of Biology and Medicine , 89 (1), 37‑47.
Cabassi, A., Tedeschi, S., Perlini, S., Verzicco, I., Volpi, R., Gonzi,
G., & Canale, S. D. (2020). Non-steroidal anti-inflammatory drug
effects on renal and cardiovascular function : From physiology to
clinical practice. European Journal of Preventive Cardiology ,27 (8), 850‑867. https://doi.org/10.1177/2047487319848105
Cho, S., & Atwood, J. E. (2002). Peripheral edema. The American
Journal of Medicine , 113 (7), 580‑586.
https://doi.org/10.1016/s0002-9343(02)01322-0
Cluze, C., Rey, D., Huiart, L., BenDiane, M. K., Bouhnik, A. D.,
Berenger, C., … Giorgi, R. (2012). Adjuvant endocrine therapy
with tamoxifen in young women with breast cancer : Determinants of
interruptions vary over time. Annals of Oncology: Official Journal
of the European Society for Medical Oncology , 23 (4), 882‑890.
https://doi.org/10.1093/annonc/mdr330
Cracowski, J.-L., & Roustit, M. (2020). Human Skin Microcirculation.Comprehensive Physiology , 10 (Issue 3), 1105–1154.
https://doi.org/10.1002/cphy.c190008
D’Angelo, S. P., Kris, M. G., Pietanza, M. C., Rizvi, N. A., & Azzoli,
C. G. (2011). A case series of dose-limiting peripheral edema observed
in patients treated with pemetrexed. Journal of Thoracic Oncology:
Official Publication of the International Association for the Study of
Lung Cancer , 6 (3), 624‑626.
https://doi.org/10.1097/JTO.0b013e318207f788
Daniell, K. M., Bardia, A., Sun, F., Roberts, S. A., Brunelle, C. L.,
Gillespie, T. C., … Taghian, A. G. (2019). Incidence of
peripheral edema in patients receiving PI3K/mTOR/CDK4/6 inhibitors for
metastatic breast cancer. Breast Cancer Research and Treatment ,175 (3), 649‑658. https://doi.org/10.1007/s10549-019-05206-y
Das, N., Baumgartner, R. N., Riley, E. C., Pinkston, C. M., Yang, D., &
Baumgartner, K. B. (2015). Treatment-related risk factors for arm
lymphedema among long-term breast cancer survivors. Journal of
Cancer Survivorship: Research and Practice , 9 (3), 422‑430.
https://doi.org/10.1007/s11764-014-0416-9
de la Sierra, A. (2009). Mitigation of calcium channel blocker-related
oedema in hypertension by antagonists of the renin-angiotensin system.Journal of Human Hypertension , 23 (8), 503‑511.
https://doi.org/10.1038/jhh.2008.157
Druey, K. M., & Parikh, S. M. (2017). Idiopathic systemic capillary
leak syndrome (Clarkson disease). Journal of Allergy and Clinical
Immunology , 140 (3), 663‑670.
https://doi.org/10.1016/j.jaci.2016.10.042
Estato, V., Araújo, C. V., Bousquet, P., & Tibiriçá, E. (2004). Effects
of centrally acting antihypertensive drugs on the microcirculation of
spontaneously hypertensive rats. Brazilian Journal of Medical and
Biological Research = Revista Brasileira De Pesquisas Medicas E
Biologicas , 37 (10), 1541‑1549.
https://doi.org/10.1590/s0100-879x2004001000014
European Association for the Study of the Liver. Electronic address:
easloffice@easloffice.eu, Clinical Practice Guideline Panel: Chair:,
Panel members, & EASL Governing Board representative: (2019). EASL
Clinical Practice Guidelines : Drug-induced liver injury. Journal
of Hepatology , 70 (6), 1222‑1261.
https://doi.org/10.1016/j.jhep.2019.02.014
Fereydooni, A., Dardik, A., & Nassiri, N. (2019). Molecular changes
associated with vascular malformations. Journal of Vascular
Surgery , 70 (1), 314-326.e1.
https://doi.org/10.1016/j.jvs.2018.12.033
Freynhagen, R., Serpell, M., Emir, B., Whalen, E., Parsons, B., Clair,
A., & Latymer, M. (2015). A comprehensive drug safety evaluation of
pregabalin in peripheral neuropathic pain. Pain Practice: The
Official Journal of World Institute of Pain , 15 (1), 47‑57.
https://doi.org/10.1111/papr.12146
Frishman, W. H. (2002). Effects of nonsteroidal anti-inflammatory drug
therapy on blood pressure and peripheral edema. The American
Journal of Cardiology , 89 (6A), 18D-25D.
https://doi.org/10.1016/s0002-9149(02)02233-6
García-Gutiérrez, V., & Hernández-Boluda, J. C. (2019). Tyrosine Kinase
Inhibitors Available for Chronic Myeloid Leukemia : Efficacy and
Safety. Frontiers in Oncology , 9 , 603.
https://doi.org/10.3389/fonc.2019.00603
Gardner-Nix, J. (2002). Opioids causing peripheral edema. Journal
of Pain and Symptom Management , 23 (6), 453‑455.
https://doi.org/10.1016/s0885-3924(02)00404-9
Gharbi, C., Gueutin, V., & Izzedine, H. (2014). Oedema, solid organ
transplantation and mammalian target of rapamycin
inhibitor/proliferation signal inhibitors (mTOR-I/PSIs). Clinical
Kidney Journal , 7 (2), 115‑120.
https://doi.org/10.1093/ckj/sfu001
Giles, F. J., O’Dwyer, M., & Swords, R. (2009). Class effects of
tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia.Leukemia , 23 (10), 1698‑1707.
https://doi.org/10.1038/leu.2009.111
Grada, A. A., & Phillips, T. J. (2017). Lymphedema : Pathophysiology
and clinical manifestations. Journal of the American Academy of
Dermatology , 77 (6), 1009‑1020.
https://doi.org/10.1016/j.jaad.2017.03.022
Gustafsson, D., Länne, T., Bjerkhoel, P., Johansson, P., & Lundvall, J.
(1989). Microvascular effects and oedema formation of felodipine in man.Journal of Hypertension. Supplement: Official Journal of the
International Society of Hypertension , 7 (4), S161-167;
discussion S168.
Hack, S. P., Bruey, J.-M., & Koeppen, H. (2014). HGF/MET-directed
therapeutics in gastroesophageal cancer : A review of clinical and
biomarker development. Oncotarget , 5 (10), 2866‑2880.
https://doi.org/10.18632/oncotarget.2003
Hazem, A., Elamin, M. B., Bancos, I., Malaga, G., Prutsky, G., Domecq,
J. P., … Murad, M. H. (2012). Body composition and quality of
life in adults treated with GH therapy : A systematic review and
meta-analysis. European Journal of Endocrinology , 166 (1),
13‑20. https://doi.org/10.1530/EJE-11-0558
Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2008).
Chronotherapy with nifedipine GITS in hypertensive patients : Improved
efficacy and safety with bedtime dosing. American Journal of
Hypertension , 21 (8), 948‑954.
https://doi.org/10.1038/ajh.2008.216
Hinchcliff, M. E., Lomasney, J., Johnson, J. A., & Varga, J. (2016).
Fulminant capillary leak syndrome in a patient with systemic sclerosis
treated with imatinib mesylate. Rheumatology (Oxford, England) ,55 (10), 1916‑1918. https://doi.org/10.1093/rheumatology/kew245
Hosseini, S. H., & Ahmadi, A. (2012). Peripheral Edema Occurring during
Treatment with Risperidone Combined with Citalopram. Case Reports
in Medicine , 2012 , 540732. https://doi.org/10.1155/2012/540732
Huber, S., Bruns, C. J., Schmid, G., Hermann, P. C., Conrad, C., Niess,
H., … Guba, M. (2007). Inhibition of the mammalian target of
rapamycin impedes lymphangiogenesis. Kidney International ,71 (8), 771‑777. https://doi.org/10.1038/sj.ki.5002112
Iabichella, M. L., Dell’Omo, G., Melillo, E., & Pedrinelli, R. (1997).
Calcium channel blockers blunt postural cutaneous vasoconstriction in
hypertensive patients. Hypertension (Dallas, Tex.: 1979) ,29 (3), 751‑756. https://doi.org/10.1161/01.hyp.29.3.751
Izzedine, H., El-Fekih, R. K., & Perazella, M. A. (2016). The renal
effects of ALK inhibitors. Investigational New Drugs ,34 (5), 643‑649. https://doi.org/10.1007/s10637-016-0379-y
Jeong, G. H., Lee, K. H., Lee, I. R., Oh, J. H., Kim, D. W., Shin, J.
W., … Shin, J. I. (2019). Incidence of Capillary Leak Syndrome as
an Adverse Effect of Drugs in Cancer Patients : A Systematic Review and
Meta-Analysis. Journal of Clinical Medicine , 8 (2).
https://doi.org/10.3390/jcm8020143
Kamenicky, P., Viengchareun, S., Blanchard, A., Meduri, G., Zizzari, P.,
Imbert-Teboul, M., … Lombès, M. (2008). Epithelial sodium channel
is a key mediator of growth hormone-induced sodium retention in
acromegaly. Endocrinology , 149 (7), 3294‑3305.
https://doi.org/10.1210/en.2008-0143
Kim, K. W., Shinagare, A. B., Krajewski, K. M., Pyo, J., Tirumani, S.
H., Jagannathan, J. P., & Ramaiya, N. H. (2015). Fluid retention
associated with imatinib treatment in patients with gastrointestinal
stromal tumor : Quantitative radiologic assessment and implications for
management. Korean Journal of Radiology , 16 (2), 304‑313.
https://doi.org/10.3348/kjr.2015.16.2.304
Komatsu, Y., Nakamura, A., Takihata, M., Inoue, Y., Yahagi, S., Tajima,
K., … Terauchi, Y. (2016). Safety and tolerability of diazoxide
in Japanese patients with hyperinsulinemic hypoglycemia. Endocrine
Journal , 63 (3), 311‑314.
https://doi.org/10.1507/endocrj.EJ15-0428
Lalande, S., & Romero, S. A. (2019). The shear complexity of
insulin-stimulated vasodilatation. The Journal of Physiology ,597 (1), 11. https://doi.org/10.1113/JP277324
Low, P. A. (2004). 38—Venoarteriolar Reflex. In D. Robertson, I.
Biaggioni, G. Burnstock, & P. A. Low (Éds.), Primer on the
Autonomic Nervous System (Second Edition) (p. 152‑153). San Diego:
Academic Press. https://doi.org/10.1016/B978-012589762-4/50039-6
Mahé, E., Morelon, E., Lechaton, S., Sang, K.-H. L. Q., Mansouri, R.,
Ducasse, M.-F., … Bodemer, C. (2005). Cutaneous adverse events in
renal transplant recipients receiving sirolimus-based therapy.Transplantation , 79 (4), 476‑482.
https://doi.org/10.1097/01.tp.0000151630.25127.3a
Mahé, I., Chassany, O., Grenard, A.-S., Caulin, C., & Bergmann, J.-F.
(2004). Methadone and edema : A case-report and literature review.European Journal of Clinical Pharmacology , 59 (12),
923‑924. https://doi.org/10.1007/s00228-003-0712-1
Makani, H., Bangalore, S., Romero, J., Htyte, N., Berrios, R. S.,
Makwana, H., & Messerli, F. H. (2011). Peripheral edema associated with
calcium channel blockers : Incidence and withdrawal rate–a
meta-analysis of randomized trials. Journal of Hypertension ,29 (7), 1270‑1280. https://doi.org/10.1097/HJH.0b013e3283472643
Makani, H., Bangalore, S., Romero, J., Wever-Pinzon, O., & Messerli, F.
H. (2011). Effect of renin-angiotensin system blockade on calcium
channel blocker-associated peripheral edema. The American Journal
of Medicine , 124 (2), 128‑135.
https://doi.org/10.1016/j.amjmed.2010.08.007
Markowitz, G. S., Bomback, A. S., & Perazella, M. A. (2015).
Drug-induced glomerular disease : Direct cellular injury.Clinical Journal of the American Society of Nephrology: CJASN ,10 (7), 1291‑1299. https://doi.org/10.2215/CJN.00860115
Mertz, P., Lebrun-Vignes, B., Salem, J.-E., & Arnaud, L. (2019).
Characterizing drug-induced capillary leak syndromes using the World
Health Organization VigiBase. The Journal of Allergy and Clinical
Immunology , 143 (1), 433‑436.
https://doi.org/10.1016/j.jaci.2018.09.001
Messerli, F. H. (2002). Vasodilatory edema : A common side effect of
antihypertensive therapy. Current Cardiology Reports ,4 (6), 479‑482. https://doi.org/10.1007/s11886-002-0110-9
Messing, M., Van Essen, H., Smith, T. L., Smits, J. F., &
Struyker-Boudier, H. A. (1991). Microvascular actions of calcium channel
antagonists. European Journal of Pharmacology , 198 (2‑3),
189‑195. https://doi.org/10.1016/0014-2999(91)90620-6
Michel, C. C., Woodcock, T. E., & Curry, F.-R. E. (2020). Understanding
and extending the Starling principle. Acta Anaesthesiologica
Scandinavica . https://doi.org/10.1111/aas.13603
Morfoisse, F., Tatin, F., Chaput, B., Therville, N., Vaysse, C.,
Métivier, R., … Garmy-Susini, B. (2018). Lymphatic Vasculature
Requires Estrogen Receptor-α Signaling to Protect From Lymphedema.Arteriosclerosis, Thrombosis, and Vascular Biology , 38 (6),
1346‑1357. https://doi.org/10.1161/ATVBAHA.118.310997
Page, R. L., O’Bryant, C. L., Cheng, D., Dow, T. J., Ky, B., Stein, C.
M., … American Heart Association Clinical Pharmacology and Heart
Failure and Transplantation Committees of the Council on Clinical
Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on
Cardiovascular and Stroke Nursing; and Council on Quality of Care and
Outcomes Research. (2016). Drugs That May Cause or Exacerbate Heart
Failure : A Scientific Statement From the American Heart Association.Circulation , 134 (6), e32-69.
https://doi.org/10.1161/CIR.0000000000000426
Park, S. I., Jeon, W. H., Jeung, H. J., Kim, G. C., Kim, D. K., & Sim,
Y.-J. (2014). Clinical features of docetaxel chemotherapy-related
lymphedema. Lymphatic Research and Biology , 12 (3),
197‑202. https://doi.org/10.1089/lrb.2013.0037
Pedrinelli, R., Dell’Omo, G., & Mariani, M. (2001). Calcium channel
blockers, postural vasoconstriction and dependent oedema in essential
hypertension. Journal of Human Hypertension , 15 (7),
455‑461. https://doi.org/10.1038/sj.jhh.1001201
Perez-Lloret, S., Rey, M. V., Crispo, J., Krewski, D., Lapeyre-Mestre,
M., Montastruc, J.-L., & Rascol, O. (2014). Risk of heart failure
following treatment with dopamine agonists in Parkinson’s disease
patients. Expert Opinion on Drug Safety , 13 (3), 351‑360.
https://doi.org/10.1517/14740338.2014.888057
Quinkler, M., Bujalska, I. J., Kaur, K., Onyimba, C. U., Buhner, S.,
Allolio, B., … Stewart, P. M. (2005). Androgen receptor-mediated
regulation of the alpha-subunit of the epithelial sodium channel in
human kidney. Hypertension (Dallas, Tex.: 1979) , 46 (4),
787‑798. https://doi.org/10.1161/01.HYP.0000184362.61744.c1
Rashid-Farokhi, F., & Afshar, H. (2017). Lymphedema of the Transplanted
Kidney and Abdominal Wall with Ipsilateral Pleural Effusion Following
Kidney Biopsy in a Patient Treated with Sirolimus : A Case Report and
Review of the Literature. The American Journal of Case Reports ,18 , 1370‑1376. https://doi.org/10.12659/ajcr.905962
Ravi, P. B., Ravishankar, G. M., & Andrade, C. (2014). Bilateral
peripheral edema as a rare adverse effect of escitalopram. Indian
Journal of Psychiatry , 56 (1), 97.
https://doi.org/10.4103/0019-5545.124735
Retailleau, K., Arhatte, M., Demolombe, S., Peyronnet, R., Baudrie, V.,
Jodar, M., … Honoré, E. (2016). Arterial Myogenic Activation
through Smooth Muscle Filamin A. Cell Reports , 14 (9),
2050‑2058. https://doi.org/10.1016/j.celrep.2016.02.019
Rizzo, A. N., Aman, J., van Nieuw Amerongen, G. P., & Dudek, S. M.
(2015). Targeting Abl kinases to regulate vascular leak during sepsis
and acute respiratory distress syndrome. Arteriosclerosis,
Thrombosis, and Vascular Biology , 35 (5), 1071‑1079.
https://doi.org/10.1161/ATVBAHA.115.305085
Robert, N. J., & Denduluri, N. (2018). Patient Case Lessons :
Endocrine Management of Advanced Breast Cancer. Clinical Breast
Cancer , 18 (3), 192‑204.
https://doi.org/10.1016/j.clbc.2017.05.014
Savage, R. D., Visentin, J. D., Bronskill, S. E., Wang, X., Gruneir, A.,
Giannakeas, V., … McCarthy, L. M. (2020). Evaluation of a Common
Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older
Adults With Hypertension. JAMA Internal Medicine .
https://doi.org/10.1001/jamainternmed.2019.7087
Scallan, J., Huxley, V. H., & Korthuis, R. J. (2010). Capillary
Fluid Exchange : Regulation, Functions, and Pathology . San Rafael
(CA): Morgan & Claypool Life Sciences. Consulté à l’adresse
http://www.ncbi.nlm.nih.gov/books/NBK53447/
Sibaud, V., Lebœuf, N. R., Roche, H., Belum, V. R., Gladieff, L.,
Deslandres, M., … Lacouture, M. E. (2016). Dermatological adverse
events with taxane chemotherapy. European journal of
dermatology : EJD , 26 (5), 427‑443.
https://doi.org/10.1684/ejd.2016.2833
Sica, D. A. (2003). Calcium channel blocker-related periperal edema :
Can it be resolved? Journal of Clinical Hypertension (Greenwich,
Conn.) , 5 (4), 291‑294, 297.
https://doi.org/10.1111/j.1524-6175.2003.02402.x
Sica, D. A. (2005). Alpha1-adrenergic blockers : Current usage
considerations. Journal of Clinical Hypertension (Greenwich,
Conn.) , 7 (12), 757‑762.
https://doi.org/10.1111/j.1524-6175.2005.05300.x
Siddall, E., Khatri, M., & Radhakrishnan, J. (2017). Capillary leak
syndrome : Etiologies, pathophysiology, and management. Kidney
International , 92 (1), 37‑46.
https://doi.org/10.1016/j.kint.2016.11.029
Stachenfeld, N. S. (2008). Sex hormone effects on body fluid regulation.Exercise and Sport Sciences Reviews , 36 (3), 152‑159.
https://doi.org/10.1097/JES.0b013e31817be928
Tan, E. K., & Ondo, W. (2000). Clinical characteristics of
pramipexole-induced peripheral edema. Archives of Neurology ,57 (5), 729‑732. https://doi.org/10.1001/archneur.57.5.729
Tan, E.-K. (2007). Peripheral edema and dopamine agonists in Parkinson
disease. Archives of Neurology , 64 (10), 1546‑1547; author
reply 1547. https://doi.org/10.1001/archneur.64.10.1546-b
Tuman, T. C., Tuman, B., Tuman, T. C., & Tuman, B. (2018). A rare side
effect of escitalopram : Bilateral peripheral edema. Archives of
Clinical Psychiatry (São Paulo) , 45 (2), 51‑52.
https://doi.org/10.1590/0101-60830000000156
Tykocki, N. R., Boerman, E. M., & Jackson, W. F. (2017). Smooth Muscle
Ion Channels and Regulation of Vascular Tone in Resistance Arteries and
Arterioles. Comprehensive Physiology , 7 (2), 485‑581.
https://doi.org/10.1002/cphy.c160011
Uguz, F. (2014). Rapid weight gain associated with edema after use of
paroxetine and venlafaxine : 2 case reports. Clinical
Neuropharmacology , 37 (1), 34‑35.
https://doi.org/10.1097/WNF.0000000000000012
Umar, M. U., & Abdullahi, A. T. (2016). Self-limiting Atypical
Antipsychotics-induced Edema : Clinical Cases and Systematic Review.Indian Journal of Psychological Medicine , 38 (3), 182‑188.
https://doi.org/10.4103/0253-7176.183089
van Hamersvelt, H. W., Kloke, H. J., de Jong, D. J., Koene, R. A., &
Huysmans, F. T. (1996). Oedema formation with the vasodilators
nifedipine and diazoxide : Direct local effect or sodium retention?Journal of Hypertension , 14 (8), 1041‑1045.
Veizi, E., Tornero-Bold, M., & Hayek, S. M. (2016). Resolution of
Intrathecal Hydromorphone or Morphine-induced Peripheral Edema by Opioid
Rotation to Fentanyl : A Case Series. Pain Practice: The Official
Journal of World Institute of Pain , 16 (6), E94-98.
https://doi.org/10.1111/papr.12443
Vercauteren, M., Trensz, F., Pasquali, A., Cattaneo, C., Strasser, D.
S., Hess, P., … Clozel, M. (2017). Endothelin ETA Receptor
Blockade, by Activating ETB Receptors, Increases Vascular Permeability
and Induces Exaggerated Fluid Retention. The Journal of
Pharmacology and Experimental Therapeutics , 361 (2), 322‑333.
https://doi.org/10.1124/jpet.116.234930
Vouri, S. M., Jiang, X., Manini, T. M., Solberg, L. M., Pepine, C.,
Malone, D. C., & Winterstein, A. G. (2019). Magnitude of and
Characteristics Associated With the Treatment of Calcium Channel
Blocker-Induced Lower-Extremity Edema With Loop Diuretics. JAMA
Network Open , 2 (12), e1918425.
https://doi.org/10.1001/jamanetworkopen.2019.18425
Vukadinović, D., Scholz, S. S., Messerli, F. H., Weber, M. A., Williams,
B., Böhm, M., & Mahfoud, F. (2019). Peripheral edema and headache
associated with amlodipine treatment : A meta-analysis of randomized,
placebo-controlled trials. Journal of Hypertension ,37 (10), 2093‑2103. https://doi.org/10.1097/HJH.0000000000002145
Walker, C., & Biasucci, L. M. (2018). Cardiovascular safety of
non-steroidal anti-inflammatory drugs revisited. Postgraduate
Medicine , 130 (1), 55‑71.
https://doi.org/10.1080/00325481.2018.1412799
Walker, G., Xenophontos, M., Chen, L., & Cheung, K. (2013). Long-term
efficacy and safety of exemestane in the treatment of breast cancer.Patient Preference and Adherence , 7 , 245‑258.
https://doi.org/10.2147/PPA.S42223
Wang, M., Xu, Y., Wen, G.-Z., Wang, Q., & Yuan, S.-M. (2019). Rapamycin
suppresses angiogenesis and lymphangiogenesis in melanoma by
downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression.OncoTargets and Therapy , 12 , 4643‑4654.
https://doi.org/10.2147/OTT.S205160
Wei, A., Gu, Z., Li, J., Liu, X., Wu, X., Han, Y., & Pu, J. (2016).
Clinical Adverse Effects of Endothelin Receptor Antagonists : Insights
From the Meta-Analysis of 4894 Patients From 24 Randomized Double-Blind
Placebo-Controlled Clinical Trials. Journal of the American Heart
Association , 5 (11). https://doi.org/10.1161/JAHA.116.003896
Whelton, A. (1995). Renal effects of over-the-counter analgesics.Journal of Clinical Pharmacology , 35 (5), 454‑463.
https://doi.org/10.1002/j.1552-4604.1995.tb04088.x
Whelton, A. (2000). Renal and related cardiovascular effects of
conventional and COX-2-specific NSAIDs and non-NSAID analgesics.American Journal of Therapeutics , 7 (2), 63‑74.
https://doi.org/10.1097/00045391-200007020-00004
Wiffen, P. J., Derry, S., Bell, R. F., Rice, A. S., Tölle, T. R.,
Phillips, T., & Moore, R. A. (2017). Gabapentin for chronic neuropathic
pain in adults. The Cochrane Database of Systematic Reviews ,6 , CD007938. https://doi.org/10.1002/14651858.CD007938.pub4
Wood, L. D. (2010). Clinical review and treatment of select adverse
effects of dopamine receptor agonists in Parkinson’s disease.Drugs & Aging , 27 (4), 295‑310.
https://doi.org/10.2165/11318330-000000000-00000
Yeo, P. M., Koh, W. L., & Lim, S. P. R. (2016). Tramadol-induced
peripheral oedema. Clinical and Experimental Dermatology ,41 (5), 557‑558. https://doi.org/10.1111/ced.12822
Zamora, A., Alves, M., Chollet, C., Therville, N., Fougeray, T., Tatin,
F., … Garmy-Susini, B. (2019). Paclitaxel induces lymphatic
endothelial cells autophagy to promote metastasis. Cell Death &
Disease , 10 (12), 956. https://doi.org/10.1038/s41419-019-2181-1
Zaza, G., Tomei, P., Ria, P., Granata, S., Boschiero, L., & Lupo, A.
(2013). Systemic and nonrenal adverse effects occurring in renal
transplant patients treated with mTOR inhibitors. Clinical &
Developmental Immunology , 2013 , 403280.
https://doi.org/10.1155/2013/403280
Zeng, C., Zhang, M., Asico, L. D., Eisner, G. M., & Jose, P. A. (2007).
The dopaminergic system in hypertension. Clinical Science (London,
England: 1979) , 112 (12), 583‑597.
https://doi.org/10.1042/CS20070018
Zhang, W., & Mifflin, S. (2010). Plasticity of GABAergic mechanisms
within the nucleus of the solitary tract in hypertension.Hypertension (Dallas, Tex.: 1979) , 55 (2), 201‑206.
https://doi.org/10.1161/HYPERTENSIONAHA.109.146407